The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

ग्रंथसूची विवरण
मुख्य लेखकों: Barnett, G, Flashman, E, Kelly, D, Schofield, C, Gershlick, A
स्वरूप: Conference item
प्रकाशित: 2013
विवरण
सारांश:

समान संसाधन